CSI Market
Sign In | Register

Medicines Co (MDCO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MDCO quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Medicines Co adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2018)
12 Months 		(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Operating Activities
Income-123.16
Depreciation & amortization3.20
Amortization of Other Assets27.92
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability4.82
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories1.81
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-28.58
Share-based Compensation18.07
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.06
Impairment Of Investments-
Investment Income Net Amortization Of Discount And Premium-
Available For Sale Securities Gross Realized Gain Loss Net-
Cost Method Investments Realized Gain Loss-
Adjustmentto Contingent Consideration-
Gain Losson Disposition of Business and Discontinued Operation Gain Loss from Disposal of Discontinued Operationbefore Income Tax-168.96
Gain Loss On Disposition Of Business And Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax-3.23
Payment For Contingent Consideration Liability Operating Activities-
Income taxes0.00
Gain (Loss) on Investments51.90
Increase (Decrease) in Accounts Receivable4.96
Increase (Decrease) in Accounts Payable-9.51
Increase (Decrease) in Accrued Liabilities-50.39
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets9.66
Other Working Capital-0.17
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.08
Discontinued operations0.00
Net Cash flow from Operating Activities-261.80
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items12.67
Proceeds from Sale and Maturity of Available-for-sale Securities0.00
Payments to Acquire Available-for-sale Securities0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale and Maturity of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Other Payments to Acquire Businesses0.00
Payments to Acquire Equity Method Investments0.00
Proceeds from Divestiture of Businesses166.38
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities179.05
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-5.46
Long-term debt - borrowings163.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock15.61
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.51
Payments for Milestone Payment-
Collaborative Arrangement Milestone Payment-
Proceeds From Issuance Public Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities172.63
Effect of exchange rate on cash flow-1.77
Discontinued operations0.00
Free Cash Flow-249.13
Total Cash Flow88.12
4 historic quarters locked

Sign in to unlock the full Medicines Co cash flow history.

Sign In Create Free Account

About MDCO Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License